Tradewinds Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2
| Closed | -$1.13K | – | 727 |
|
|
2025
Q3 | $1.13K | Buy |
+2
| New | +$1.13K | ﹤0.01% | 563 |
|
|
2022
Q2 | – | Sell |
-294
| Closed | -$205K | – | 707 |
|
|
2022
Q1 | $205K | Hold |
294
| – | – | 0.03% | 117 |
|
|
2021
Q4 | $186K | Hold |
294
| – | – | 0.03% | 131 |
|
|
2021
Q3 | $178K | Buy |
294
+44
| +18% | +$27.3K | 0.03% | 125 |
|
|
2021
Q2 | $140K | Hold |
250
| – | – | 0.03% | 142 |
|
|
2021
Q1 | $118K | Hold |
250
| – | – | 0.02% | 144 |
|
|
2020
Q4 | $121K | Hold |
250
| – | – | 0.03% | 142 |
|
|
2020
Q3 | $140K | Sell |
250
-10
| -4% | -$6.06K | 0.03% | 117 |
|
|
2020
Q2 | $162K | Buy |
260
+10
| +4% | +$5.68K | 0.04% | 104 |
|
|
2020
Q1 | $122K | Sell |
250
-15
| -6% | -$6.19K | 0.04% | 108 |
|
|
2019
Q4 | $100K | Buy |
265
+165
| +165% | +$55.5K | 0.03% | 145 |
|
|
2019
Q3 | $28K | Hold |
100
| – | – | 0.01% | 233 |
|
|
2019
Q2 | $31K | Hold |
100
| – | – | 0.01% | 219 |
|
|
2019
Q1 | $41K | Hold |
100
| – | – | 0.02% | 203 |
|
|
2018
Q4 | $37K | Hold |
100
| – | – | 0.02% | 208 |
|
|
2018
Q3 | $40K | Hold |
100
| – | – | 0.02% | 238 |
|
|
2018
Q2 | $34K | Hold |
100
| – | – | 0.01% | 251 |
|
|
2018
Q1 | $34K | Hold |
100
| – | – | 0.02% | 243 |
|
|
2017
Q4 | $38K | Hold |
100
| – | – | 0.02% | 237 |
|
|
2017
Q3 | $45K | Hold |
100
| – | – | 0.02% | 217 |
|
|
2017
Q2 | $49K | Hold |
100
| – | – | 0.03% | 205 |
|
|
2017
Q1 | $39K | Hold |
100
| – | – | 0.02% | 226 |
|
|
2016
Q4 | $37K | Hold |
100
| – | – | 0.02% | 232 |
|
|
2016
Q3 | $40K | Hold |
100
| – | – | 0.03% | 220 |
|
|
2016
Q2 | $35K | Hold |
100
| – | – | 0.03% | 234 |
|
|
2016
Q1 | $36K | Hold |
100
| – | – | 0.02% | 253 |
|
|
2015
Q4 | $54K | Hold |
100
| – | – | 0.04% | 209 |
|
|
2015
Q3 | $47K | Hold |
100
| – | – | 0.04% | 214 |
|
|
2015
Q2 | $51K | Hold |
100
| – | – | 0.04% | 224 |
|
|
2015
Q1 | $45K | Hold |
100
| – | – | 0.03% | 221 |
|
|
2014
Q4 | $41K | Hold |
100
| – | – | 0.03% | 231 |
|
|
2014
Q3 | $36K | Hold |
100
| – | – | 0.03% | 238 |
|
|
2014
Q2 | $28K | Hold |
100
| – | – | 0.02% | 272 |
|
|
2014
Q1 | $30K | Hold |
100
| – | – | 0.02% | 271 |
|
|
2013
Q4 | $28K | Buy |
+100
| New | +$28.8K | 0.02% | 265 |
|
Other funds holding REGN
Tradewinds Capital Management's REGN Position: Q4 2025 in Review
Tradewinds Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 2 shares — an estimated $1.13K sold.
Tradewinds Capital Management first reported a position in REGN in Q4 2013 and held it in 35 quarters. The position peaked at $205K in Q1 2022. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.
- Tradewinds Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Tradewinds Capital Management sold 2 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $1.13K.
- Tradewinds Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 35 quarters.
- Tradewinds Capital Management's Regeneron Pharmaceuticals position peaked at $205K in Q1 2022.
- 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.
Based on Tradewinds Capital Management's 13F filing for Q4 2025, filed 14 Jan 2026.